TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $152,923,000 | +62.5% | 5,552,786 | -2.7% | 0.00% | +33.3% |
| Q1 2021 | $94,116,000 | -6.1% | 5,707,412 | +4.9% | 0.00% | 0.0% |
| Q4 2020 | $100,271,000 | +39.2% | 5,440,640 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $72,036,000 | -14.1% | 5,292,872 | +13.1% | 0.00% | 0.0% |
| Q2 2020 | $83,840,000 | +163.3% | 4,678,624 | +46.5% | 0.00% | +50.0% |
| Q1 2020 | $31,836,000 | +23.8% | 3,193,058 | +1.1% | 0.00% | +100.0% |
| Q4 2019 | $25,711,000 | -6.8% | 3,158,571 | +13.4% | 0.00% | 0.0% |
| Q3 2019 | $27,592,000 | -13.1% | 2,784,399 | +10.7% | 0.00% | 0.0% |
| Q2 2019 | $31,769,000 | +58.6% | 2,515,392 | +28.0% | 0.00% | 0.0% |
| Q1 2019 | $20,029,000 | +171.9% | 1,965,575 | +100.1% | 0.00% | – |
| Q4 2018 | $7,367,000 | +72.6% | 982,405 | +130.2% | 0.00% | – |
| Q3 2018 | $4,268,000 | +125.0% | 426,770 | +184.4% | 0.00% | – |
| Q2 2018 | $1,897,000 | – | 150,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |